Issue 07 — Editorial
Evidence before hype.
A quiet, independent reading room for people who want the mechanism, the method and the caveats — not the marketing.
Latest articles
48 articles
Research · 5 September 2026 · 11 min read
BPC-157: What the Preclinical Evidence Shows and Why No Human Trial Data Exists
BPC-157 is one of the most discussed research peptides online, built almost entirely on animal studies from a single research group. A careful reading of what is published, what regulators have said, and what remains unproven.
Read
Research · 5 September 2026 · 12 min read
Growth Hormone Secretagogues: One Approved Drug, Several Research Compounds, and the Difference
Tesamorelin is an FDA-approved medicine with phase 3 trial data. Ipamorelin and sermorelin are not approved for general use and rest on far thinner evidence. What separates a licensed GHRH analogue from an online 'GH peptide'.
Research · 5 September 2026 · 10 min read
Semaglutide vs Tirzepatide: What the Head-to-Head Trial Evidence Actually Shows
Two approved incretin medicines, one direct comparison trial and a great deal of confusion in between. A source-checked reading of STEP 1, SURMOUNT-1, SURPASS-2 and the open-label SURMOUNT-5 comparison.
Recovery · 5 September 2026 · 10 min read
Thymosin Beta-4 and TB-500: What Is Established, and What Is Simply Assumed
TB-500 is routinely described as the healing peptide for tendons and muscle. It is a fragment of a naturally occurring protein with a real preclinical literature — and a human evidence base that stops well short of the claims.
Longevity · 5 September 2026 · 9 min read
GHK-Cu: What the Copper Peptide Research Supports, and Where It Stops
GHK-Cu is the copper peptide behind a large part of the peptide skincare category. The laboratory and gene-expression literature is substantial; the controlled clinical literature in humans is much thinner than the marketing suggests.
Research · 31 August 2026 · 6 min read
Investigational Peptides and Nociceptive Pathways: A Desk Review of Preclinical Candidates
An editorial evaluation of preclinical peptide compounds targeting inflammatory signaling, tissue regeneration, and neuropathic pathways in chronic pain research.
Recovery · 31 August 2026 · 5 min read
Physiological Mechanisms of Targeted Respiratory Training: Diaphragmatic Mechanics, Autonomic Modulation, and Recovery Kinetics
An examination of controlled respiratory interventions, evaluating how diaphragmatic pacing, hypercapnic conditioning, and autonomic modulation influence pulmonary efficiency and post-exertional recovery.
Research · 31 August 2026 · 5 min read
Pharmacokinetic Dynamics: Evaluating Delivery Routes and Systemic Bioavailability in Research
An analysis of how administration routes—from parenteral injections to mucosal and oral vectors—impact systemic exposure, metabolic degradation, and pharmacokinetic outcomes in experimental models.
Recovery · 31 August 2026 · 5 min read
Systematic Post-Exercise Recovery: A Methodological Review of 24-Hour Kinetics
An analytical evaluation of post-training recovery frameworks, examining physiological substrate restoration, parasympathetic tone re-establishment, and cellular repair timelines over a 24-hour cycle.
Recovery · 31 August 2026 · 4 min read
Diagnostic Markers of Inadequate Recovery: An Analytical Framework for Overreaching and Autonomic Strain
An examination of key physiological and neuroendocrine warning signs signaling non-functional overreaching, autonomic nervous system imbalance, and systemic recovery deficits in high-demand research models.
Longevity · 31 August 2026 · 5 min read
Sustained Adaptation Over Acute Exertion: A Physiological Perspective on Protocol Consistency
An editorial evaluation of how steady, sub-maximal stressors yield superior tissue adaptation and longevity compared to sporadic, high-amplitude heroic effort.
Research · 31 August 2026 · 5 min read
Evaluating Mod GRF 1-29 (CJC-1295 Without DAC): Secretagogue Kinetics, Receptor Dynamics, and Experimental Limitations
An editorial review examining the short-acting GHRH analog Mod GRF 1-29 (CJC-1295 no DAC), its physiological mechanism, pulsatile release profiles, and comparative distinction from long-acting formulations.
Recovery · 31 August 2026 · 5 min read
Analyzing High-Profile Polytrauma Recovery: Peptides, Physiology, and the Evidence Gap
An editorial analysis of high-profile orthopedic recovery narratives, examining the biological mechanisms of polytrauma repair, preclinical peptide signaling, and the methodological challenges of multi-modal rehabilitation.